| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,923 |
10,297 |
$839K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,753 |
5,541 |
$353K |
| 86328 |
|
3,618 |
2,925 |
$109K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,679 |
2,959 |
$88K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,985 |
2,480 |
$84K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,868 |
6,973 |
$78K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
417 |
417 |
$39K |
| 90674 |
|
1,270 |
1,243 |
$31K |
| 99406 |
|
3,935 |
3,589 |
$27K |
| 20610 |
|
846 |
736 |
$27K |
| 20552 |
|
878 |
802 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,936 |
950 |
$22K |
| 94010 |
|
1,372 |
1,363 |
$21K |
| 80305 |
|
4,572 |
3,750 |
$18K |
| 96160 |
|
983 |
978 |
$15K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,488 |
1,454 |
$13K |
| 93000 |
|
1,698 |
1,665 |
$13K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
156 |
156 |
$11K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,839 |
2,468 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
924 |
859 |
$11K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,024 |
5,008 |
$10K |
| 81002 |
|
4,566 |
4,152 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,358 |
1,216 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
3,144 |
2,998 |
$8K |
| 80306 |
|
577 |
472 |
$7K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,204 |
1,153 |
$6K |
| 90756 |
|
288 |
279 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
885 |
863 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
48 |
47 |
$3K |
| 0011A |
|
86 |
86 |
$3K |
| 99215 |
Prolong outpt/office vis |
29 |
28 |
$3K |
| 99386 |
|
15 |
15 |
$2K |
| 0012A |
|
49 |
49 |
$2K |
| 82948 |
|
397 |
345 |
$2K |
| 82962 |
|
834 |
740 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
27 |
21 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,286 |
1,139 |
$1K |
| 36416 |
|
631 |
564 |
$985.00 |
| 99408 |
|
60 |
60 |
$897.28 |
| 0031A |
|
24 |
24 |
$883.45 |
| 69210 |
|
27 |
27 |
$864.05 |
| 82270 |
|
246 |
244 |
$664.79 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
42 |
42 |
$599.07 |
| 90658 |
|
53 |
53 |
$579.42 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
47 |
45 |
$358.26 |
| 97803 |
|
2,088 |
1,813 |
$160.00 |
| 97802 |
|
150 |
146 |
$125.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14 |
12 |
$3.74 |
| J1071 |
Injection, testosterone cypionate, 1 mg |
52 |
38 |
$2.69 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
141 |
124 |
$0.69 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
489 |
447 |
$0.48 |
| 3074F |
|
8,210 |
6,632 |
$0.10 |
| 3079F |
|
6,905 |
5,724 |
$0.07 |
| 3078F |
|
4,017 |
3,465 |
$0.07 |
| 3075F |
|
2,756 |
2,467 |
$0.04 |
| 3008F |
|
1,673 |
1,342 |
$0.03 |
| 3080F |
|
455 |
424 |
$0.01 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,102 |
1,093 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
2,574 |
2,050 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
560 |
510 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,579 |
1,246 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
107 |
100 |
$0.00 |
| G8422 |
Bmi not documented, documentation the patient is not eligible for bmi calculation |
55 |
49 |
$0.00 |
| 94760 |
|
64 |
60 |
$0.00 |
| 4000F |
|
54 |
53 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
15 |
15 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
12 |
12 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
16 |
12 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,379 |
1,366 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
9,879 |
7,574 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,516 |
1,210 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
41 |
40 |
$0.00 |
| 99173 |
|
52 |
50 |
$0.00 |
| 3077F |
|
372 |
351 |
$0.00 |
| 99497 |
|
17 |
17 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
39 |
38 |
$0.00 |
| 3288F |
|
16 |
16 |
$0.00 |